D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 94 Citations 23,469 260 World Ranking 355 National Ranking 223
Medicine D-index 103 Citations 28,636 313 World Ranking 3242 National Ranking 1862

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Virus
  • Immune system

Peter L. Collins spends much of his time researching Virology, Virus, Molecular biology, Paramyxoviridae and Immunology. Peter L. Collins is involved in the study of Virology that focuses on Respiratory syncytial virus in particular. His study of Viral replication is a part of Virus.

His Molecular biology research is multidisciplinary, relying on both Amino acid and Peptide sequence, Transcription, Gene. His studies deal with areas such as Attenuated vaccine and Interferon as well as Paramyxoviridae. In his study, which falls under the umbrella issue of Immunology, Adenosine, Secretion, Cystic fibrosis transmembrane conductance regulator and Hormone transport is strongly linked to Cell biology.

His most cited work include:

  • 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) (719 citations)
  • The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins (454 citations)
  • Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious Cytopathology (412 citations)

What are the main themes of his work throughout his whole career to date?

Peter L. Collins mostly deals with Virology, Virus, Viral replication, Molecular biology and Gene. Peter L. Collins specializes in Virology, namely Paramyxoviridae. The various areas that Peter L. Collins examines in his Paramyxoviridae study include Sendai virus and Vaccinia.

He combines subjects such as Attenuated vaccine, Recombinant virus, Immune system and Microbiology with his study of Virus. His Viral replication research includes themes of Interferon, Syncytium, Glycoprotein, Reverse genetics and Virulence. While the research belongs to areas of Molecular biology, he spends his time largely on the problem of Mutant, intersecting his research to questions surrounding Mutation.

He most often published in these fields:

  • Virology (74.80%)
  • Virus (62.47%)
  • Viral replication (22.31%)

What were the highlights of his more recent work (between 2013-2021)?

  • Virology (74.80%)
  • Virus (62.47%)
  • Immunogenicity (11.02%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Virology, Virus, Immunogenicity, Viral replication and Antibody. Peter L. Collins has researched Virology in several fields, including Attenuated vaccine and Recombinant DNA. He is studying Respiratory syncytial virus, which is a component of Virus.

His work deals with themes such as Vero cell, Respiratory Syncytial Virus Vaccines, Codon usage bias, Fusion protein and Open reading frame, which intersect with Immunogenicity. Peter L. Collins works mostly in the field of Viral replication, limiting it down to topics relating to Virulence and, in certain cases, Microbiology and Cleavage. His Antigen research incorporates themes from Mutant, Viral matrix protein, Messenger RNA, Transcription and Nasal administration.

Between 2013 and 2021, his most popular works were:

  • 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) (719 citations)
  • Taxonomy of the order Mononegavirales: update 2016 (307 citations)
  • 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (215 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Virus
  • Immune system

His main research concerns Virology, Virus, Immunogenicity, Viral replication and Attenuated vaccine. His Virology study incorporates themes from Taxonomy, Cytokine and A549 cell. His biological study spans a wide range of topics, including RNA virus, Gene and Microbiology.

His study in Immunogenicity is interdisciplinary in nature, drawing from both Respiratory Syncytial Virus Vaccines, Neutralizing antibody and Fusion protein. Peter L. Collins has included themes like Antigen and Nasal administration in his Antibody study. The Immunology study combines topics in areas such as Airway and Respiratory system.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)

Francesco Cosentino;Peter J Grant;Victor Aboyans;Clifford J Bailey.
European Heart Journal (2020)

1116 Citations

The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins

Philip R. Johnson;Melanie K. Spriggs;Robert A. Olmsted;Peter L. Collins.
Proceedings of the National Academy of Sciences of the United States of America (1987)

696 Citations

Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious Cytopathology

Liqun Zhang;Mark E. Peeples;Richard C. Boucher;Peter L. Collins.
Journal of Virology (2002)

577 Citations

Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology.

Marco Stramba-Badiale;Kim M. Fox;Silvia G. Priori;Peter Collins.
European Heart Journal (2006)

560 Citations

Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease

G.M.C. Rosano;P.M. Sarrel;P.A. Poole-Wilson;P. Collins.
The Lancet (1993)

555 Citations

Endothelium‐independent relaxation of rabbit coronary artery by 17β‐oestradiol in vitro

Canwen Jiang;Philip M. Sarrel;David C. Lindsay;Philip A. Poole-Wilson.
British Journal of Pharmacology (1991)

520 Citations

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

Himani Bisht;Anjeanette Roberts;Leatrice Vogel;Alexander Bukreyev.
Proceedings of the National Academy of Sciences of the United States of America (2004)

432 Citations

Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity

Robert A. Olmsted;Narayanasamy Elango;Gregory A. Prince;Brian R. Murphy.
Proceedings of the National Academy of Sciences of the United States of America (1986)

422 Citations

Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein

G W Wertz;P L Collins;Y Huang;C Gruber.
Proceedings of the National Academy of Sciences of the United States of America (1985)

392 Citations

A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease

Fernando P. Polack;Michael N. Teng;Peter L.Collins;Gregory A. Prince.
Journal of Experimental Medicine (2002)

379 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peter L. Collins

José A. Melero

José A. Melero

Instituto de Salud Carlos III

Publications: 84

Barney S. Graham

Barney S. Graham

National Institutes of Health

Publications: 79

Ralph A. Tripp

Ralph A. Tripp

University of Georgia

Publications: 71

Siba K. Samal

Siba K. Samal

Virginia Tech

Publications: 70

Heinz Feldmann

Heinz Feldmann

National Institutes of Health

Publications: 70

John V. Williams

John V. Williams

University of Pittsburgh

Publications: 68

Mark E. Peeples

Mark E. Peeples

The Ohio State University

Publications: 66

Edward E. Walsh

Edward E. Walsh

Rochester Regional Health

Publications: 63

James E. Crowe

James E. Crowe

Vanderbilt University Medical Center

Publications: 60

Martin L. Moore

Martin L. Moore

Emory University

Publications: 59

Alexis M. Kalergis

Alexis M. Kalergis

Pontificia Universidad Católica de Chile

Publications: 58

Peter J. M. Openshaw

Peter J. M. Openshaw

National Institutes of Health

Publications: 58

Yoshihiro Kawaoka

Yoshihiro Kawaoka

University of Tokyo

Publications: 52

Albert D. M. E. Osterhaus

Albert D. M. E. Osterhaus

University of Veterinary Medicine Hannover, Foundation

Publications: 50

Andrew J. Easton

Andrew J. Easton

University of Warwick

Publications: 49

Brian R. Murphy

Brian R. Murphy

National Institutes of Health

Publications: 48

Trending Scientists

Philip Resnik

Philip Resnik

University of Maryland, College Park

Anderson Rocha

Anderson Rocha

State University of Campinas

Patrick C. Flood

Patrick C. Flood

Dublin City University

Anugeetha Kunjithapatham

Anugeetha Kunjithapatham

Samsung (South Korea)

Costas Kiparissides

Costas Kiparissides

Aristotle University of Thessaloniki

Kuan-Neng Chen

Kuan-Neng Chen

National Yang Ming Chiao Tung University

Takehiko Nohmi

Takehiko Nohmi

Gifu University

Giovanna Chimini

Giovanna Chimini

Inserm : Institut national de la santé et de la recherche médicale

Paul Nettesheim

Paul Nettesheim

National Institutes of Health

Vicente Andrés

Vicente Andrés

Spanish National Centre for Cardiovascular Research

Shigenobu Takeda

Shigenobu Takeda

Nagasaki University

Georg Wohlfahrt

Georg Wohlfahrt

University of Innsbruck

John G. Parnavelas

John G. Parnavelas

University College London

Mélanie Boly

Mélanie Boly

University of Wisconsin–Madison

Michel Marre

Michel Marre

Université Paris Cité

Wen-Ping Chen

Wen-Ping Chen

National Central University

Something went wrong. Please try again later.